Homocysteine as a predictor of cognitive decline in Alzheimer's disease
Objective: Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established Alzheimer...
Auteurs principaux: | Oulhaj, A, Refsum, H, Beaumont, H, Williams, J, King, E, Jacoby, R, Smith, A |
---|---|
Autres auteurs: | International College of Geriatric Psychoneuropharmacology |
Format: | Journal article |
Langue: | English |
Publié: |
John Wiley & Sons, Ltd.
2010
|
Sujets: |
Documents similaires
-
Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
par: Oulhaj, A, et autres
Publié: (2010) -
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
par: Smith, A, et autres
Publié: (2010) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
par: de Jager, C, et autres
Publié: (2012) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
par: De Jager, C, et autres
Publié: (2012) -
Cognitive deficits in severe mood disorder: similar or different from schizophrenia?
par: Goodwin, G
Publié: (2003)